4.5  Interaction  with other medicinal  products and other forms of interaction  
 No interaction studies have been performed.  
 The nature of Libmeldy is such that no pharmacokinetic  interactions are expected  with other medicinal products . 
 Patients should not take anti -retroviral medicinal products from at least one month prior to mobilisation until at least 7  days after Libmeldy infusion (see section 4.4).  
 Live vaccines  
 The safety of immunisation with live viral vaccines during or following treatment with Libmeldy has  not been studied. As a precautionary measure, vaccination with live vaccines is not recommended for at least  6 weeks prior to the start of myeloablative con ditioning, during Libmeldy treatment, and until haematological recovery following treatment.  
 
